Use of 4CMenB vaccine in the control of an outbreak of serogroup B invasive meningococcal disease in an elderly care home, England, November 2023
In November 2023, a cluster of two invasive meningococcal disease (IMD) cases caused by serogroup B Neisseria meningitidis (MenB) occurred in elderly residents (≥ 70 years) of a dementia care home in England. An epidemiological investigation was conducted and public health actions, including infecti...
Saved in:
| Main Author: | Shamez N Ladhani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Centre for Disease Prevention and Control
2025-04-01
|
| Series: | Eurosurveillance |
| Subjects: | |
| Online Access: | https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2025.30.16.2400673 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB)
by: Adriana Efron, et al.
Published: (2023-12-01) -
4CMenB journey to the 10-year anniversary and beyond
by: Véronique Abitbol, et al.
Published: (2024-12-01) -
Meningococcal vaccine 4CMenB elicits a robust cellular immune response that targets but is not consistently protective against Neisseria gonorrhoeae during murine vaginal infection
by: Joseph J. Zeppa, et al.
Published: (2025-05-01) -
Available evidence on the co-administration of the four-component meningococcal B vaccine (4CMenB) with three vaccines at the same visit among pediatric individuals
by: Paolo Bonanni, et al.
Published: (2024-12-01) -
Immunogenicity and safety of meningococcal vaccines, MenACWY-CRM and 4CMenB, in groups at increased risk for meningococcal disease
by: Shravani Bobde, et al.
Published: (2025-12-01)